Zynex Announces Completion of Its Laser Pulse Oximetry Trial
Portfolio Pulse from
Zynex, Inc. has completed its clinical verification trial for the NiCO™ pulse oximeter, a noninvasive medical device, under the supervision of Dr. David MacLeod at Duke University.
December 05, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zynex, Inc. has successfully completed a clinical trial for its NiCO™ pulse oximeter, potentially enhancing its product portfolio and market position.
The completion of the clinical trial for the NiCO™ pulse oximeter is a positive development for Zynex, as it may lead to product approval and commercialization, potentially increasing revenue and market share. This news is likely to have a positive short-term impact on ZYXI's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100